Last updated on August 2019

Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program


Brief description of study

The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.

Detailed Study Description

Subjects will be participating in a lung cancer screening program at enrollment. Subjects will have a blood sample collected within 60 days of a low-dose CT scan (LDCT). Subjects with nodules present on the LDCT or subjects with a clean LDCT scheduled for a 12-month follow-up may have another blood draw at 12 months.

Clinical Study Identifier: NCT03628638

Find a site near you

Start Over

Safe Harbor Clinical Research

East Providence, RI United States
8.47miles
  Connect »